ALX Oncology Holdings, Inc. (ALXO)
1.91
-0.13
(-6.37%)
USD |
NASDAQ |
Mar 30, 16:00
1.905
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings EPS Diluted (Quarterly) : -0.4209 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| ADMA Biologics, Inc. | 0.2025 |
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Coherus Oncology, Inc. | -0.3097 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.85M |
| Total Expenses (Quarterly) | 22.85M |
| Enterprise Value | 221.35M |
| Earnings Yield | -99.27% |
| Normalized Earnings Yield | -97.09 |